Latest / Stagflation Conversations with Fexingo: High Inflation, Slow Growth, and 1970s Echoes
How Stagflation Is Reshaping the Generic Drug Industry
Import prices from China just hit their highest level since 2008, and that's bad news for generic drug makers who rely on Chinese and Indian suppliers for active pharmaceutical ingredients. In this episode of Stagflation Conversations with Fexingo, Lucas and Luna examine how rising input costs, tariff threats, and a slowing economy are squeezing the generic drug supply chain. They reference the latest CPI and import price data, discuss the proposed 2028 tariffs on generic drugs, and consider what it means for your pharmacy bill. A focused look at one of the most inflation-sensitive…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.